Mark Latina, MD
Ophthalmology · Reading, MANPI 1801886346
Payments from drug & device makers
Across 973 payments — averaging $305.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$166K
- Sight Sciences, Inc.$58K
- Alcon$43K
- Aerie Pharmaceuticals, Inc.$24K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$609
- Tarsus Pharmaceuticals, Inc.$600
- plus $6K from 26 others
Across 1 payment — averaging $10.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$10
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 451 | $165,704 |
| Sight Sciences, Inc. | 82 | $58,334 |
| Alcon | 129 | $42,562 |
| Aerie Pharmaceuticals, Inc. | 54 | $23,640 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 38 | $609 |
| Tarsus Pharmaceuticals, Inc. | 13 | $600 |
| Glaukos Corporation | 8 | $598 |
| Amgen(2 entities) | 24 | $589 |
| Sun Pharmaceutical Industries Inc. | 20 | $574 |
| Iridex Corporation | 4 | $530 |
| Bausch & Lomb Americas Inc. | 32 | $505 |
| Mallinckrodt Hospital Products Inc. | 16 | $469 |
| Dompe US, Inc. | 10 | $416 |
| Thea Pharma Inc. | 28 | $360 |
| Oyster Point Pharma, Inc. | 8 | $326 |
| Novartis | 11 | $194 |
| Kala Pharmaceuticals, Inc. | 16 | $181 |
| Lumibird Medical Inc. | 1 | $154 |
| Biotissue Holdings Inc. | 8 | $154 |
| NEW World Medical,inc. | 4 | $125 |
| Regeneron Healthcare Solutions, Inc. | 1 | $120 |
| ANI Pharmaceuticals, Inc. | 4 | $102 |
| Visionix USA, Inc | 1 | $95 |
| Omeros Corporation | 2 | $27 |
| Akorn, Inc. | 1 | $25 |
| Rxsight Inc | 1 | $23 |
| Eyepoint US, Inc. | 1 | $22 |
| Shire North American Group Inc | 1 | $22 |
| Alimera Sciences, Inc. | 1 | $21 |
| Eyevance Pharmaceuticals LLC | 1 | $18 |
| Rayner Intraocular Lenses Limited | 1 | $17 |
| Merz North America, Inc. | 1 | $16 |
How this compares
$297,131 in reported general payments places this provider in the 95th percentile of 653 ophthalmology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Reading
- Gail TorkildsenAndover$5.1M
- David LallySpringfield$4.5M
- Jennifer SunBoston$4.2M
- Lloyd AielloBoston$3.1M
- Rishi SinghBoston$2.5M
- Rachel HuckfeldtStoneham$1.7M
- Mark AbelsonAndover$1.3M
- Peter ChangWaltham$1M
- Stephen AnesiWaltham$922K
- Charles FosterWaltham$888K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.